NEPH Nephros
- 2.110
- +0.020+0.96%
- 2.170
- +0.060+2.84%
Nephros News
Nephros | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Nephros | 8-K: Current report
Nephros | S-3: Registration statement for specified transactions by certain issuers
Nephros | 8-K: Nephros Announces Financial Results for Quarter Ended March 31, 2024 First-Quarter Net Revenue of $3.5 Million; Technology advancements and microplastics capabilities on the horizon
Nephros | 8-K: Current report
Nephros | DEFA14A: Others
Nephros | DEF 14A: Definitive information statements
Nephros | 8-K: Nephros Announces Fourth Quarter and Fiscal Year 2023 Financial Results Full-Year Net Revenue of $14.2 Million and Fourth-Quarter Net Revenue of $3.3 Million
Nephros | 8-K: Current report
Nephros | 8-K: Nephros Announces Results for Quarter Ended June 30, 2023 Second-Quarter Net Revenue of $3.5 Million, a 24% Increase Over 2022; Year-to-Date Revenue Increases 45%; Maintains Positive Cash Flow Results
Nephros | 8-K: Current report
Nephros | 8-K: Current report
Nephros | DEFA14A: Others
Nephros | DEFA14A: Others
Nephros | DEF 14A: Definitive proxy statements
Nephros | 8-K: Nephros Announces Preliminary Results for First Quarter 2023 Net Revenue of $3.7 Million, a 69% Year-Over-Year Increase
Nephros | 8-K: Nephros Announces Fourth Quarter and Fiscal Year 2022 Financial Results Full-Year Net Revenue of $10 Million and Fourth Quarter Net Revenue of $2.6 Million
Nephros | 8-K: Current report
Nephros | 8-K: Nephros Announces Preliminary Results for Fourth Quarter and Fiscal Year 2022 Fourth Quarter Net Revenue of $2.6 Million; Full-Year Net Revenue of $10.0 Million; Active Customer Sites Continue to Climb
Nephros | 8-K: Current report
Analysis
Price Target
No Data
